Alpha 2.0
Login Register
» Articles » PMID: 9225962

Growth Factors in Human Ovarian Cancer

Overview
Journal Cancer Treat Rev
Publisher Elsevier
Specialty Oncology
Date 1997 Mar 1
PMID 9225962
Citations 7
Authors
A M Westermann
J H Beijnen
W H Moolenaar
S Rodenhuis
Affiliations
Soon will be listed here.
Citing Articles

A Novel ZIP4-HDAC4-VEGFA Axis in High-Grade Serous Ovarian Cancer.

Fan Q, Li L, Wang T, Emerson R, Xu Y Cancers (Basel). 2021; 13(15).

PMID: 34359722 PMC: 8345154. DOI: 10.3390/cancers13153821.

Lysophospholipid Signaling in the Epithelial Ovarian Cancer Tumor Microenvironment.

Xu Y Cancers (Basel). 2018; 10(7).

PMID: 29987226 PMC: 6071084. DOI: 10.3390/cancers10070227.

Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review.

Uppendahl L, Dahl C, Miller J, Felices M, Geller M Front Immunol. 2018; 8:1825.

PMID: 29354116 PMC: 5760535. DOI: 10.3389/fimmu.2017.01825.

Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer.

Puiffe M, Le Page C, Filali-Mouhim A, Zietarska M, Ouellet V, Tonin P Neoplasia. 2007; 9(10):820-9.

PMID: 17971902 PMC: 2040209. DOI: 10.1593/neo.07472.

SPARC inhibits LPA-mediated mesothelial-ovarian cancer cell crosstalk.

Said N, Najwer I, Socha M, Fulton D, C Mok S, Motamed K Neoplasia. 2007; 9(1):23-35.

PMID: 17325741 PMC: 1803033. DOI: 10.1593/neo.06658.